EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for EVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -0.4464
March 31, 2026 -0.4366
December 31, 2025 -0.8933
September 30, 2025 0.7227
June 30, 2025 -0.7753
March 31, 2025 -0.2862
December 31, 2024 -3.144
September 30, 2024 -1.756
June 30, 2024 -1.145
March 31, 2024 0.2554
December 31, 2023 -1.668
September 30, 2023 -2.042
June 30, 2023 -2.098
March 31, 2023 -2.431
Date Value
December 31, 2022 -2.870
September 30, 2022 -2.396
June 30, 2022 -2.042
March 31, 2022 -2.490
December 31, 2021 -3.852
September 30, 2021 -2.726
June 30, 2021 -3.595
March 31, 2021 -2.294
December 31, 2020 -2.638
September 30, 2020 -2.228
June 30, 2020 -1.912
March 31, 2020 -9.565
December 31, 2019 -2.185

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Autolus Therapeutics Plc -0.1472
Cellectis SA -0.2165
Akari Therapeutics Plc -2.404
DBV Technologies SA -0.5804
argenx SE --

EPS Diluted (Quarterly) Related Metrics